EMERGENT BIOSOLUT (Germany) Performance
| ER4 Stock | EUR 6.78 0.52 7.12% |
The firm shows a Beta (market volatility) of 0.51, which means possible diversification benefits within a given portfolio. As returns on the market increase, EMERGENT BIOSOLUT's returns are expected to increase less than the market. However, during the bear market, the loss of holding EMERGENT BIOSOLUT is expected to be smaller as well. At this point, EMERGENT BIOSOLUT has a negative expected return of -0.47%. Please make sure to confirm EMERGENT BIOSOLUT's coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if EMERGENT BIOSOLUT performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days EMERGENT BIOSOLUT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in March 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
| Begin Period Cash Flow | 576.3 M | |
| Free Cash Flow | -149.9 M |
EMERGENT |
EMERGENT BIOSOLUT Relative Risk vs. Return Landscape
If you would invest 950.00 in EMERGENT BIOSOLUT on November 28, 2024 and sell it today you would lose (272.00) from holding EMERGENT BIOSOLUT or give up 28.63% of portfolio value over 90 days. EMERGENT BIOSOLUT is producing return of less than zero assuming 4.2175% volatility of returns over the 90 days investment horizon. Simply put, 37% of all stocks have less volatile historical return distribution than EMERGENT BIOSOLUT, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
EMERGENT BIOSOLUT Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for EMERGENT BIOSOLUT's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as EMERGENT BIOSOLUT, and traders can use it to determine the average amount a EMERGENT BIOSOLUT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1124
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ER4 |
Estimated Market Risk
| 4.22 actual daily | 37 63% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average EMERGENT BIOSOLUT is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of EMERGENT BIOSOLUT by adding EMERGENT BIOSOLUT to a well-diversified portfolio.
EMERGENT BIOSOLUT Fundamentals Growth
EMERGENT Stock prices reflect investors' perceptions of the future prospects and financial health of EMERGENT BIOSOLUT, and EMERGENT BIOSOLUT fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EMERGENT Stock performance.
| Current Valuation | 1.34 B | |||
| Price To Book | 0.43 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 1.12 B | |||
| EBITDA | (41.1 M) | |||
| Total Debt | 448.5 M | |||
| Cash Flow From Operations | (34.1 M) | |||
| Total Asset | 3.17 B | |||
About EMERGENT BIOSOLUT Performance
By analyzing EMERGENT BIOSOLUT's fundamental ratios, stakeholders can gain valuable insights into EMERGENT BIOSOLUT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if EMERGENT BIOSOLUT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if EMERGENT BIOSOLUT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about EMERGENT BIOSOLUT performance evaluation
Checking the ongoing alerts about EMERGENT BIOSOLUT for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for EMERGENT BIOSOLUT help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| EMERGENT BIOSOLUT generated a negative expected return over the last 90 days | |
| EMERGENT BIOSOLUT has high historical volatility and very poor performance | |
| EMERGENT BIOSOLUT has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 1.12 B. Net Loss for the year was (223.8 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| EMERGENT BIOSOLUT generates negative cash flow from operations |
- Analyzing EMERGENT BIOSOLUT's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EMERGENT BIOSOLUT's stock is overvalued or undervalued compared to its peers.
- Examining EMERGENT BIOSOLUT's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EMERGENT BIOSOLUT's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EMERGENT BIOSOLUT's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EMERGENT BIOSOLUT's stock. These opinions can provide insight into EMERGENT BIOSOLUT's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for EMERGENT Stock analysis
When running EMERGENT BIOSOLUT's price analysis, check to measure EMERGENT BIOSOLUT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMERGENT BIOSOLUT is operating at the current time. Most of EMERGENT BIOSOLUT's value examination focuses on studying past and present price action to predict the probability of EMERGENT BIOSOLUT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMERGENT BIOSOLUT's price. Additionally, you may evaluate how the addition of EMERGENT BIOSOLUT to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |